Background. ceRNAs (competing endogenous RNAs) are a newly identified type of regulatory RNA. Accumulating evidence suggests that ceRNAs play an important role in the pathogenesis of diseases such as cancer. Thus, ceRNA dysregulation may represent an important molecular mechanism underlying cancer progression and poor prognosis. In this study, we aimed to identify ceRNAs that may serve as potential biomarkers for early diagnosis of lung adenocarcinoma (LUAD). Methods. We performed differential gene expression analysis on TCGA-LUAD datasets to identify differentially expressed (DE) mRNAs, lncRNAs, and miRNAs at different tumor stages. Based on the ceRNA hypothesis and considering the synergistic or feedback regulation of ceRNAs, a lncRNA-miRNA-mRNA network was constructed. Functional analysis was performed using GO term and KEGG pathway enrichment analysis and KOBAS 2.0 software. Transcription factor analysis was carried out to identify direct targets of the transcription factors associated with LUAD prognosis. Identified differentially expressed genes were validated using GEO datasets.
= min( , ) ∑ = ( )( --) ( ) 115 In the above formula, N represents the total number of miRNAs, K is the number of miRNAs 116 targeting mRNA, n is the number of miRNAs targeting lncRNA, and c is the number of miRNAs 117 shared by the mRNA and lncRNA. Only ceRNA modules with FDR < 0.05 were considered. 118 119 Gene functional enrichment analysis 120 In order to investigate key mRNAs at molecular and functional level, Gene Ontology (GO) and 121 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway function enrichment analysis was 122 performed. GOseq, which uses Wallenius' noncentral hypergeometric distribution model taking 123 gene length bias into account, was used to perform GO enrichment analysis. GO terms with p-124 value less than 0.05 were considered significantly enriched. KOBAS 2.0 software was used to 125 test statistical enrichment in KEGG pathways, and those with a Fisher's exact test p-value of less 126 than 0.05 was considered to be significantly enriched (Xie et al. 2011).
136 direct targets, we used RcisTarget (Aibar et al. 2017; Imrichova et al. 2015) to perform cis-137 regulatory motif analysis of each TF regulon. RcisTarget is an R-package that identifies TF 138 binding motifs that are over-represented in a gene list. We used the database, scoring 500 bp 139 upstream of TSS, and only motifs with a Normalized Enrichment Score (NES) > 3.0 were 140 considered associated with TFs of interest. 141 142 Validation of gene expression with GEO data 143 In order to validate the key differentially expressed molecules, we examined four datasets from 144 among the Gene Expression Omnibus (GEO) datasets. Of the selected datasets, the GSE10072 145 study contained 58 LUAD tumor and 49 non-tumor tissue mRNA expression data, GSE32863 146 contained 58 LUAD tumor and 58 non-tumor tissue mRNA expression data, GSE85716 147 contained 6 LUAD tumor and 6 non-tumor tissue lncRNA expression data, and GSE104854 148 contained 3 LUAD (pooled from 9 tissues) and 3 non-tumor (pooled from 9 tissues) expression 149 data. GSE10072, GSE32863, and GSE85716 datasets, which were derived from microarray data, 150 were analyzed with GEO2R online. The GSE104854 dataset, which was obtained by high 151 throughput sequencing, was analyzed with DESeq2 R package based on read counts. 152 153 Statistical analysis 154 To investigate the impact of the expression level of RNAs on the prognostic survival of patients, 155 survival analysis was performed. In the analysis, Kaplan-Meier survival analyses and log-rank 156 test were performed to study the relationship between RNA expression states (cutoff point: 157 median value) and survival time. Univariate cox proportional hazards regression was applied to 158 identify the RNAs associated with overall survival. In order to evaluate the potential of 159 dysregulated ceRNA modules as biomarkers, the risk scoring classifier was constructed. For each 160 ceRNA module, we calculated the risk score for multivariate survival analysis to determine the 161 prognostic influence of the RNAs as a whole. All statistical analyses were performed using R 162 version 3.4.3 software. 166 Among the LUAD datasets, expression data for 19669 mRNAs, 7309 lncRNAs, and 1882 167 miRNAs were extracted from TCGA and analyzed with R package (DESeq2). In this analysis, 168 we compared adjacent normal lung tissue with lung cancer subtypes defined by pathology stage 169 (T1-T4), respectively. When we combined these four groups and analyzed for differentially 170 expressed RNAs, 2160 mRNAs (1527 up-and 1083 down-regulated), 915 lncRNAs (662 up-242 FENDRR differential expression. As shown in Fig. 8 and Table 2 , all four molecules showed 243 significantly lower levels of expression in tumor datasets, which is consistent with the results of 244 our study. . 271 In this study, analysis showed that a number of mRNAs, lncRNAs, and miRNAs that were 272 differentially expressed were common at each stage of lung cancer. GO and KEGG analysis 273 showed that the DEGs were mainly involved in "single-organism cellular process", "single-274 multicellular organism process", "cell proliferation", "cell adhesion", "system development", 275 "cell migration", and "cell adhesion biological processes". Further analysis revealed that the up-276 regulated genes were involved in the mitotic cell cycle and nuclear division process (Table S3) , 277 while down-regulated genes were involved in vasculature development, cell motility, cell 278 migration, and cell proliferation (Table S4 ). KEGG analysis found that the up-regulated genes 279 were mainly involved in cancer and other related signaling pathways such as the p53 signaling 280 pathway. 281 282 Survival curve analysis reveals the correlation between gene expression and patient prognosis. 283 Our study found that the five most important ceRNA-related RNA molecules were significantly 284 correlated with the survival rate of patients with lung cancer (P < 0.01), and most of the genes 285 were highly correlated with cancer. The five ceRNA interactions consisted of one lncRNA, three 286 mRNAs, and four miRNAs. The lncRNA, FENDRR (Grote et al. 2013), which is produced from 287 a spliced long non-coding RNA transcribed bidirectionally with FOXF1 on the opposite strand, 288 is be down-regulated in both breast cancer and gastric cancer. In breast cancer, lower expression 289 level of FENDRR was associated with shorter overall survival and progression-free survival in 290 breast cancer patients. FENDRR knockdown promoted breast cancer cell proliferation and 291 migration, and suppressed cell apoptosis; in contrast, its overexpression inhibited tumor growth 292 in a xenograft model (Li et al. 2018) . FENDRR was also reported to be down-regulated in gastric 293 cancer cell lines and tissues. Further, FENDRR expression was negatively correlated with tumor 294 metastasis and stage (Xu et al. 2014). In our study, FENDRR was also down-regulated in LUAD, 295 and showed the highest degree in ceRNA network, indicating its important role in LUAD. The 296 three mRNAs, FOXF1, EDNRB, and EPAS1, ranked 2 nd , 3 rd , and 4 th , respectively in the ceRNA 297 network. FOXF1 and EPAS1 are both TFs that have been associated with tumor malignancy 298 (Putra et al. 2015; Tamura et al. 2014). Our TF analysis indicated that EPAS1 directly regulates 299 13 molecules associated with LUAD, namely ADRB2, CALCRL, EMP2, FHL1, GRIA1, LGI3, 300 LIMS2, NCKAP5, RXFP1, SLC6A4, SMAD6, STX11, and TMEM100. EDNRB, a G protein-301 coupled receptor, is also closely related with tumor (Chen et al. 2013; Wuttig et al. 2012). Our 302 findings suggest that these molecules represent potential cancer-related biomarkers. 303 304 Conclusions 305 In summary, in the present study, we comprehensively analyzed the expression of key RNA 306 molecules in the progression of lung cancer and identified key RNA molecules (including 307 mRNA/lncRNA/miRNA) that were abnormally expressed in different stages of this disease. 308 Further, using the above-mentioned key RNA molecules to construct a ceRNA-gene interaction 309 network, it was found that several FOXF1-and EDNRB-related ceRNA molecules play an 310 important role in the development and progression of lung cancer, and can affect the prognosis of 311 this disease. This series of related ceRNA molecules is expected to provide a novel basis for 312 diagnosis and evaluation of prognosis, and represents potential new targets for the treatment of 313 lung cancer. 
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